AVENUE THERAPEUTICS, INC. (ATXI) › Shareholders' EquityAVENUE THERAPEUTICS, INC. (ATXI) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$5.13M2016: -$8.25M2017: $19.38M2018: -$631.0K2019: $6.80M2020: $2.36M2021: $3.45M2022: $3.90M2023: $1.58M2024: $2.80M2025: $1.83M$1.83M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$1.83M-34.5%2024$2.80M+76.8%2023$1.58M-59.5%2022$3.90M+13.2%2021$3.45M+46.3%2020$2.36M-65.3%2019$6.80M+1177.7%2018-$631.0K-103.3%2017$19.38M+335.0%2016-$8.25M-60.6%2015-$5.13M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share